http://orcid.org/0000-0003-4600-6240
Citations (124)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (38)
Hoang Linh Nguyen, Nguyen Quoc Thai & Mai Suan Li. (2023) Identifying inhibitors of NSP16-NSP10 of SARS-CoV-2 from large databases. Journal of Biomolecular Structure and Dynamics 41:15, pages 7045-7054.
Read now
Read now
Adedayo Ayodeji Lanrewaju, Abimbola Motunrayo Enitan-Folami, Martin M. Nyaga, Saheed Sabiu & Feroz Mahomed Swalaha. (2023) Metabolites profiling and cheminformatics bioprospection of selected medicinal plants against the main protease and RNA-dependent RNA polymerase of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-21.
Read now
Read now
Wahyu Eko Prasetyo, Heri Purnomo, Miracle Sadrini, Fajar Rakhman Wibowo, Maulidan Firdaus & Triana Kusumaningsih. (2023) Identification of potential bioactive natural compounds from Indonesian medicinal plants against 3-chymotrypsin-like protease (3CLpro) of SARS-CoV-2: molecular docking, ADME/T, molecular dynamic simulations, and DFT analysis. Journal of Biomolecular Structure and Dynamics 41:10, pages 4467-4484.
Read now
Read now
A. R. Ruiz-Fernández, M. Rosemblatt & T. Perez-Acle. (2022) Nanosecond pulsed electric field (nsPEF) and vaccines: a novel technique for the inactivation of SARS-CoV-2 and other viruses?. Annals of Medicine 54:1, pages 1749-1756.
Read now
Read now
Hemlata Pundir, Tanuja Joshi, Manish Pant, Sunaullah Bhat, Jyoti Pandey, Subhash Chandra & Sushma Tamta. (2022) Identification of SARS-CoV-2 RNA dependent RNA polymerase inhibitors using pharmacophore modelling, molecular docking and molecular dynamics simulation approaches. Journal of Biomolecular Structure and Dynamics 40:24, pages 13366-13377.
Read now
Read now
M. Susithra Priyadarshni, S. Isaac Kirubakaran & M. C. Harish. (2022) In silico approach to design a multi-epitopic vaccine candidate targeting the non-mutational immunogenic regions in envelope protein and surface glycoprotein of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 40:23, pages 12948-12963.
Read now
Read now
Neda Fayyazi, Tahereh Mostashari-Rad, Jahan B. Ghasemi, Mehran Mirabzadeh Ardakani & Farzad Kobarfard. (2022) Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19. Journal of Biomolecular Structure and Dynamics 40:22, pages 11787-11808.
Read now
Read now
Amir H. Irani, D. A. Steyn-Ross, Moira L. Steyn-Ross, Logan Voss & Jamie Sleigh. (2022) The molecular dynamics of possible inhibitors for SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 40:20, pages 10023-10032.
Read now
Read now
Kateryna V. Miroshnychenko & Anna V. Shestopalova. (2022) Combined use of the hepatitis C drugs and amentoflavone could interfere with binding of the spike glycoprotein of SARS-CoV-2 to ACE2: the results of a molecular simulation study. Journal of Biomolecular Structure and Dynamics 40:19, pages 8672-8686.
Read now
Read now
Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne V N, Uddhavesh Sonavane & Rajendra Joshi. (2022) Structural insight into the binding interactions of NTPs and nucleotide analogues to RNA dependent RNA polymerase of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 40:16, pages 7230-7244.
Read now
Read now
Anshuman Chandra, Meenakshi Chaudhary, Imteyaz Qamar, Nagendra Singh & Vikrant Nain. (2022) In silico identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase. Journal of Biomolecular Structure and Dynamics 40:14, pages 6534-6544.
Read now
Read now
Anshuman Chandra, Vaishali Gurjar, Mohammad Z. Ahmed, Ali S. Alqahtani, Imteyaz Qamar & Nagendra Singh. (2022) Exploring potential inhibitor of SARS-CoV2 replicase from FDA approved drugs using insilico drug discovery methods. Journal of Biomolecular Structure and Dynamics 40:12, pages 5507-5514.
Read now
Read now
Sagar Barage, A. Karthic, Rohit Bavi, Neetin Desai, Raj Kumar, Vikas Kumar & Keun Woo Lee. (2022) Identification and characterization of novel RdRp and Nsp15 inhibitors for SARS-COV2 using computational approach. Journal of Biomolecular Structure and Dynamics 40:6, pages 2557-2574.
Read now
Read now
Zouhair Elkarhat, Hicham Charoute, Lamiae Elkhattabi, Abdelhamid Barakat & Hassan Rouba. (2022) Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses. Journal of Biomolecular Structure and Dynamics 40:1, pages 361-374.
Read now
Read now
Abdus Samad, Foysal Ahammad, Zulkar Nain, Rahat Alam, Raihan Rahman Imon, Mahadi Hasan & Md. Shahedur Rahman. (2022) Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach. Journal of Biomolecular Structure and Dynamics 40:1, pages 14-30.
Read now
Read now
Soumita Mukherjee, Subrata Dasgupta, Tapasendra Adhikary, Utpal Adhikari & Sujit Sankar Panja. (2021) Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study. Journal of Biomolecular Structure and Dynamics 39:18, pages 7322-7334.
Read now
Read now
Pradeep Sharma, Viswanathan Vijayan, Pradeep Pant, Mohita Sharma, Naval Vikram, Punit Kaur, T. P. Singh & Sujata Sharma. (2021) Identification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:17, pages 6649-6659.
Read now
Read now
Nima Razzaghi-Asl, Ahmad Ebadi, Sara Shahabipour & Danial Gholamin. (2021) Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis. Journal of Biomolecular Structure and Dynamics 39:17, pages 6633-6648.
Read now
Read now
Satyam Singh, Md Fulbabu Sk, Avinash Sonawane, Parimal Kar & Sushabhan Sadhukhan. (2021) Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA‐dependent RNA polymerase (RdRp) inhibition: an in-silico analysis. Journal of Biomolecular Structure and Dynamics 39:16, pages 6249-6264.
Read now
Read now
Jitendra Subhash Rane, Preeti Pandey, Aroni Chatterjee, Rajni Khan, Abhijeet Kumar, Amresh Prakash & Shashikant Ray. (2021) Targeting virus–host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19. Journal of Biomolecular Structure and Dynamics 39:15, pages 5768-5778.
Read now
Read now
Iruthayaraj Ancy, Mugudeeswaran Sivanandam & Poomani Kumaradhas. (2021) Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study. Journal of Biomolecular Structure and Dynamics 39:15, pages 5368-5375.
Read now
Read now
Sk. Abdul Amin, Kalyan Ghosh, Shovanlal Gayen & Tarun Jha. (2021) Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors. Journal of Biomolecular Structure and Dynamics 39:13, pages 4764-4773.
Read now
Read now
K. G. Arun, C. S Sharanya, J. Abhithaj, Dileep Francis & C. Sadasivan. (2021) Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target. Journal of Biomolecular Structure and Dynamics 39:13, pages 4647-4658.
Read now
Read now
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas & Snehasis Chowdhuri. (2021) Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics 39:12, pages 4362-4374.
Read now
Read now
Rohitash Yadav, Mohammed Imran, Puneet Dhamija, Kapil Suchal & Shailendra Handu. (2021) Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:12, pages 4433-4448.
Read now
Read now
Ashimiyu B. Durojaiye, John-Ross D. Clarke, George A. Stamatiades & Can Wang. (2021) Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies. Journal of Biomolecular Structure and Dynamics 39:12, pages 4547-4554.
Read now
Read now
Amit Singh & Abha Mishra. (2021) Leucoefdin a potential inhibitor against SARS CoV-2 Mpro. Journal of Biomolecular Structure and Dynamics 39:12, pages 4427-4432.
Read now
Read now
Natarajan Arul Murugan, Chitra Jeyaraj Pandian & Jeyaraman Jeyakanthan. (2021) Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials. Journal of Biomolecular Structure and Dynamics 39:12, pages 4415-4426.
Read now
Read now
Mark Tristan J. Quimque, Kin Israel R. Notarte, Rey Arturo T. Fernandez, Mark Andrew O. Mendoza, Rhenz Alfred D. Liman, Justin Allen K. Lim, Luis Agustin E. Pilapil, Jehiel Karsten H. Ong, Adriel M. Pastrana, Abbas Khan, Dong-Qing Wei & Allan Patrick G. Macabeo. (2021) Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms. Journal of Biomolecular Structure and Dynamics 39:12, pages 4316-4333.
Read now
Read now
Anshuman Chandra, Vaishali Gurjar, Imteyaz Qamar & Nagendra Singh. (2021) Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19. Journal of Biomolecular Structure and Dynamics 39:12, pages 4201-4211.
Read now
Read now
Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma, Pankaj Tyagi, Arvind Bhushan & Madhu Rathore. (2021) Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. Journal of Biomolecular Structure and Dynamics 39:10, pages 3760-3770.
Read now
Read now
Satyajit Beura & Prabhakar Chetti. (2021) In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:10, pages 3747-3759.
Read now
Read now
Muhammad Tahir Khan, Arif Ali, Qiankun Wang, Muhammad Irfan, Abbas Khan, Muhammad Tariq Zeb, Yu-Juan Zhang, Sathishkumar Chinnasamy & Dong-Qing Wei. (2021) Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study. Journal of Biomolecular Structure and Dynamics 39:10, pages 3627-3637.
Read now
Read now
Md Fulbabu Sk, Rajarshi Roy, Nisha Amarnath Jonniya, Sayan Poddar & Parimal Kar. (2021) Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations. Journal of Biomolecular Structure and Dynamics 39:10, pages 3649-3661.
Read now
Read now
Khalid El Asnaoui & Youness Chawki. (2021) Using X-ray images and deep learning for automated detection of coronavirus disease. Journal of Biomolecular Structure and Dynamics 39:10, pages 3615-3626.
Read now
Read now
Ilaria Vicenti, Maurizio Zazzi & Francesco Saladini. (2021) SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19. Expert Opinion on Therapeutic Patents 31:4, pages 325-337.
Read now
Read now
Chiranjib Chakraborty, Manojit Bhattacharya, Bidyut Mallick, Ashish Ranjan Sharma, Sang-Soo Lee & Govindasamy Agoramoorthy. (2021) SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development. Expert Review of Clinical Pharmacology 14:2, pages 225-237.
Read now
Read now
Ismail Anwar, Eman Kamal El-dien Anwer & Mohamed AbdAllah. (2020) Doxycycline: a new treatment option for COVID-19. Alexandria Journal of Medicine 56:1, pages 130-131.
Read now
Read now
Articles from other publishers (86)
Xiaowei Wang, Tiantian Xu, Yuan Yao, Peter Pak-Hang Cheung, Xin Gao & Lu Zhang. (2023) SARS-CoV-2 RNA-Dependent RNA Polymerase Follows Asynchronous Translocation Pathway for Viral Transcription and Replication. The Journal of Physical Chemistry Letters 14:45, pages 10119-10128.
Crossref
Crossref
Amal Vijay, Venkata Sai Sreyas Adury & Arnab Mukherjee. (2023) Targeting RdRp of SARS-CoV-2 with De Novo Molecule Generation. ACS Applied Bio Materials.
Crossref
Crossref
Syamsul Falah, Laksmi Ambarsari, Dimas Andrianto, Rini Kurniasih & Sanro Tachibana. (2023) The potential of Myricitrin, a Flavonoid Compound in Eugenia polyantha from Indonesia, as an Antiviral Drug for SARS-Cov-2 through the Molecular Docking Analysis. Jurnal Kimia Sains dan Aplikasi 26:5, pages 166-177.
Crossref
Crossref
Manoj A. Mangukiya, Pritam V. Bagwe, Aman A. Desai & Shreerang V. Joshi. (2023) DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR DETERMINATION OF RELATED SUBSTANCES AND PURITY OF FAVIPIRAVIR DRUG SUBSTANCE. Indian Drugs 60:03, pages 64-80.
Crossref
Crossref
Udit Chaube, Bhumika D. Patel & Hardik G. Bhatt. (2022) A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2. 3 Biotech 13:1.
Crossref
Crossref
Junaida M. Ibrahim, Suveena Sukumaran & Achuthsankar S. Nair. 2023. Conservation and Sustainable Utilization of Bioresources. Conservation and Sustainable Utilization of Bioresources
531
555
.
Acharya Balkrishna, Subarna Pokhrel & Anurag Varshney. (2022)
Phyto-Compounds from a Rather Poisonous Plant,
Strychnos nuxvomica
,
Show High Potency Against SARS-CoV-2 RNA-Dependent
RNA Polymerase
. Current Molecular Medicine 22:10, pages 929-940.
Crossref
Crossref
Prabhat Ranjan, Kumar Gaurav & Tanmoy Chakraborty. (2022) Computational study of some potential inhibitors of COVID‐19: A DFT analysis. Quantitative Biology 10:4, pages 341-350.
Crossref
Crossref
Deepak Agarwal, Imran Zafar, Syed Umair Ahmad, Sujit Kumar, Qurat ul Ain, Jitendra Kumar Sundaray & Mohd Ashraf Rather. (2022) Structural, genomic information and computational analysis of emerging coronavirus (SARS-CoV-2). Bulletin of the National Research Centre 46:1.
Crossref
Crossref
Faezeh Almasi, Wen Dang, Fatemeh Mohammadipanah & Ning Li. (2022) Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms. Archives of Pharmacal Research 45:12, pages 909-937.
Crossref
Crossref
Vadim Alexandrov, Alexander Kirpich, Omar Kantidze & Yuriy Gankin. (2022)
A multi-reference poly-conformational method for
in silico
design, optimization, and repositioning of pharmaceutical compounds illustrated for selected SARS-CoV-2 ligands
. PeerJ 10, pages e14252.
Crossref
Crossref
Dylan Brunt, Phillip M. Lakernick & Chun Wu. (2022) Discovering new potential inhibitors to SARS-CoV-2 RNA dependent RNA polymerase (RdRp) using high throughput virtual screening and molecular dynamics simulations. Scientific Reports 12:1.
Crossref
Crossref
Ganesh BharskarPratik Malvade. (2022) Favipiravir: An Antiviral Drug. Research Journal of Pharmaceutical Dosage Forms and Technology, pages 253-260.
Crossref
Crossref
Pinar Mesci, Janaina S. de Souza, Laura Martin-Sancho, Angela Macia, Aurian Saleh, Xin Yin, Cedric Snethlage, Jason W. Adams, Simoni H. Avansini, Roberto H. Herai, Angels Almenar-Queralt, Yuan Pu, Ryan A. Szeto, Gabriela Goldberg, Patrick T. Bruck, Fabio Papes, Sumit K. Chanda & Alysson R. Muotri. (2022) SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir. PLOS Biology 20:11, pages e3001845.
Crossref
Crossref
Aynaz Nourani, Vahid Rahimkhoei & Ali Akbari. (2022) Potential therapeutic drug candidates against SARS-CoV-2 (COVID‐19) through molecular docking: A review. Health Science Monitor 1:2, pages 89-106.
Crossref
Crossref
Angela Parise, Giada Ciardullo, Mario Prejanò, Aurélien de la Lande & Tiziana Marino. (2022) On the Recognition of Natural Substrate CTP and Endogenous Inhibitor ddhCTP of SARS-CoV-2 RNA-Dependent RNA Polymerase: A Molecular Dynamics Study. Journal of Chemical Information and Modeling 62:20, pages 4916-4927.
Crossref
Crossref
Ishrat Husain, Rumana Ahmad, Sahabjada Siddiqui, Anu Chandra, Aparna Misra, Aditi Srivastava, Tanveer Ahamad, Mohd. Faheem Khan, Zeba Siddiqi, Anchal Trivedi, Shivbrat Upadhyay, Anamika Gupta, Anand N. Srivastava, Bilal Ahmad, Sudhir Mehrotra, Surya Kant, Abbas Ali Mahdi & Farzana Mahdi. (2022)
Structural interactions of phytoconstituent(s) from cinnamon, bay leaf, oregano, and parsley with
SARS‐CoV
‐2 nucleocapsid protein: A comparative assessment for development of potential antiviral nutraceuticals
. Journal of Food Biochemistry 46:10.
Crossref
Crossref
Inas A. Abdallah, Mohammed F. El-Behairy, Rasha M. Ahmed & Marwa A. A. Fayed. (2022) The anti-COVID-19 drug Favipiravir: Degradation, Method development, Validation, NMR/LC–MS characterization, and In-vitro safety evaluation. Chemical Papers 76:10, pages 6415-6426.
Crossref
Crossref
Ahmed O. Mohammed, Mazin I. Abo-Idrees, Alaa A. Makki, Walaa Ibraheem & Abdulrahim A. Alzain. (2022) Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics. Structural Chemistry 33:5, pages 1553-1567.
Crossref
Crossref
Abdul Manan, Rameez Hassan Pirzada, Muhammad Haseeb & Sangdun Choi. (2022) Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach. International Journal of Molecular Sciences 23:18, pages 10716.
Crossref
Crossref
Panagiotis Zagaliotis, Anthi Petrou, George Mystridis, Athina Geronikaki, Ioannis Vizirianakis & Thomas Walsh. (2022) Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling. International Journal of Molecular Sciences 23:14, pages 8006.
Crossref
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Crossref
Hilal Yilmaz, Busra Gultekin Subasi, Hasan Ufuk Celebioglu, Tugba Ozdal & Esra Capanoglu. (2022) Chemistry of Protein-Phenolic Interactions Toward the Microbiota and Microbial Infections. Frontiers in Nutrition 9.
Crossref
Crossref
Joy Y. Feng, Venice Du Pont, Darius Babusis, Calvin J. Gordon, Egor P. Tchesnokov, Jason K. Perry, Vincent Duong, Arya Vijjapurapu, Xiaofeng Zhao, Julie Chan, Cal Cohen, Kavita Juneja, Tomas Cihlar, Matthias Götte & John P. Bilello. (2022) The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2. Molecules 27:13, pages 4212.
Crossref
Crossref
S M Devraye. (2022) A Review: Remdesivir and Covid-19. International Journal of Advanced Research in Science, Communication and Technology, pages 501-506.
Crossref
Crossref
Manojit Bhattacharya, Ashish Ranjan Sharma, Pratik Ghosh, Prasanta Patra, Bidhan Chandra Patra, Sang-Soo Lee & Chiranjib Chakraborty. (2022) Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach. Molecular Biotechnology 64:5, pages 510-525.
Crossref
Crossref
Vishal Mevada, Rajesh Patel, Pravin Dudhagara, Himani Gandhi, Urvisha Beladiya, Nilam Vaghamshi, Manoj Godhaniya & Anjana Ghelani. (2022) Variant Analysis and Strategic Clustering to Sub-Lineage of Double Mutant Strain B.1.617 of SARS-CoV-2. COVID 2:5, pages 513-531.
Crossref
Crossref
Saurov Mahanta, Tufan Naiya, Kunal Biswas, Liza Changkakoti, Yugal Kishore Mohanta, Bhaben Tanti, Awdhesh Kumar Mishra, Tapan Kumar Mohanta & Nanaocha Sharma. (2022) Plant Source Derived Compound Exhibited In Silico Inhibition of Membrane Glycoprotein In SARS-CoV-2: Paving the Way to Discover a New Class of Compound For Treatment of COVID-19. Frontiers in Pharmacology 13.
Crossref
Crossref
Zhi-Gang Sun, Feng-Ling Yu, Xiang-Ting Qiu, Shuang Li, Xue-Tang Li & Hai-Liang Zhu. (2022) Promising Enzymes for Inhibitors Development Against COVID-19. Mini-Reviews in Medicinal Chemistry 22:3, pages 449-456.
Crossref
Crossref
Mohammed A. Abosheasha, Afnan H. El-Gowily & Abdo A. Elfiky. (2021) Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective. Journal of Thrombosis and Thrombolysis 53:2, pages 273-281.
Crossref
Crossref
Ismail Celik, Meryem Erol & Zekeriya Duzgun. (2021) In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase. Molecular Diversity 26:1, pages 279-292.
Crossref
Crossref
Abdo A. Elfiky, Eman B. Azzam & Medhat W. Shafaa. (2021) The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico. Molecular Diversity 26:1, pages 171-181.
Crossref
Crossref
Jaime Monserrat Villatoro, Gina Mejía-Abril, Lucía Díaz García, Pablo Zubiaur, María Jiménez González, Guillermo Fernandez Jimenez, Inés Cancio, José Ramón Arribas, Carmen Suarez Fernández, Jesús Mingorance, Julio García Rodríguez, José Ramón Villagrasa Ferrer, Antonio J. Carcas, Jesús Frías, Francisco Abad-Santos, Alberto M. Borobia & Elena Ramírez. (2022) A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis. Pharmaceuticals 15:1, pages 78.
Crossref
Crossref
Shabana Bibi, Mohammad Mehedi Hasan, Yuan-Bing Wang, Stavros P. Papadakos & Hong Yu. (2022) Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent
RNA Polymerase (RdRp). Current Medicinal Chemistry 29:1, pages 152-162.
Crossref
Crossref
Periyasamy Sellam, Sundaram Manjunathan, Srinivasan Vasanth Kumar, Kasi Chithra & Kasi Chithra. (2022) Synthesis, NMR Studies and Binding Interactions of (2E,2′E)-2,2′-(Propane-1,2-
diylidene)bis(N-methylhydrazinecarbothio-amide) with SARS-CoV Main Protease. Asian Journal of Organic & Medicinal Chemistry 7:1, pages 37-41.
Crossref
Crossref
Alejandro Morales-Bayuelo & Jesús Sánchez-Márquez. (2023) New findings on ligand series used as SARS-CoV-2 virus inhibitors within the frameworks of molecular docking, molecular quantum similarity and chemical reactivity indices. F1000Research 11, pages 914.
Crossref
Crossref
Alejandro Morales-Bayuelo & Jesús Sánchez-Márquez. (2022) New findings on ligand series used as SARS-CoV-2 virus inhibitors within the frameworks of molecular docking, molecular quantum similarity and chemical reactivity indices. F1000Research 11, pages 914.
Crossref
Crossref
Abdul Hawil Abas, Trina Ekawati Tallei, Fatimawali Fatimawali, Ismail Celik, Fahad A. Alhumaydhi, Talha Bin Emran, Kuldeep Dhama, Ali A. Rabaan, Mohammed A. Garout, Muhammad A. Halwani, Abbas Al Mutair, Saad Alhumaid & Harapan Harapan. (2023) 4’-fluorouridine as a potential COVID-19 oral drug?: a review. F1000Research 11, pages 410.
Crossref
Crossref
Abdul Hawil Abas, Trina Ekawati Tallei, Fatimawali Fatimawali, Ismail Celik, Fahad A. Alhumaydhi, Talha Bin Emran, Kuldeep Dhama, Ali A. Rabaan, Mohammed A. Garout, Muhammad A. Halwani, Abbas Al Mutair, Saad Alhumaid & Harapan Harapan. (2022) 4’-fluorouridine and its derivatives as potential COVID-19 oral drugs: a review. F1000Research 11, pages 410.
Crossref
Crossref
R. Hernández-Morales, A. Becerra, J.A. Campillo-Balderas, W.F. Cottom-Salas, A. Cruz-González, R. Jácome, A. Lazcano, I. Muñoz-Velasco & A. Vázquez-Salazar. 2022. Biomedical Innovations to Combat COVID-19. Biomedical Innovations to Combat COVID-19
65
82
.
Raghvendra Dubey & Kushagra Dubey. 2022. Modeling, Control and Drug Development for COVID-19 Outbreak Prevention. Modeling, Control and Drug Development for COVID-19 Outbreak Prevention
203
244
.
Safa MEGAHED, Ahmed HABİB, Sherin HAMMAD & Amira KAMAL. (2021) Chemometric Approach Based on Factorial and Box-Behnken Designs for Determination of Anti Coronavirus Drug; Favipiravir in Bulk and Spiked Human Plasma by Green HPLC Method. Turkish Journal of Analytical Chemistry 3:2, pages 70-78.
Crossref
Crossref
Zachary A. Krumm, Grace M. Lloyd, Connor P. Francis, Lith H. Nasif, Duane A. Mitchell, Todd E. Golde, Benoit I. Giasson & Yuxing Xia. (2021) Precision therapeutic targets for COVID-19. Virology Journal 18:1.
Crossref
Crossref
Souvik Banerjee, Shalini Yadav, Sourav Banerjee, Sayo O. Fakayode, Jyothi Parvathareddy, Walter Reichard, Surekha Surendranathan, Foyez Mahmud, Ryan Whatcott, Joshua Thammathong, Bernd Meibohm, Duane D. Miller, Colleen B. Jonsson & Kshatresh Dutta Dubey. (2021)
Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and
In Vitro
Study
. Journal of Chemical Information and Modeling 61:11, pages 5469-5483.
Crossref
Crossref
Marko Jukič, Dušanka Janežič & Urban Bren. (2021) Potential Novel Thioether-Amide or Guanidine-Linker Class of SARS-CoV-2 Virus RNA-Dependent RNA Polymerase Inhibitors Identified by High-Throughput Virtual Screening Coupled to Free-Energy Calculations. International Journal of Molecular Sciences 22:20, pages 11143.
Crossref
Crossref
Anuj Kumar, Dwijesh Chandra Mishra, Ulavappa Basavanneppa Angadi, Rashmi Yadav, Anil Rai & Dinesh Kumar. (2021) Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study. Frontiers in Chemistry 9.
Crossref
Crossref
Mansi Srivastava, Dwight Hall, Okiemute Beatrice Omoru, Hunter Mathias Gill, Sarah Smith & Sarath Chandra Janga. (2021) Mutational Landscape and Interaction of SARS-CoV-2 with Host Cellular Components. Microorganisms 9:9, pages 1794.
Crossref
Crossref
Vidushi Sharma & Sharad Wakode. (2020) Investigating the role of N-terminal domain in phosphodiesterase 4B-inhibition by molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics 39:12, pages 4270-4278.
Crossref
Crossref
Sajjad Ahmad, Hyder Wajid Abbasi, Sara Shahid, Sana Gul & Sumra Wajid Abbasi. (2020)
Molecular docking, simulation and MM-PBSA studies of
nigella sativa
compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment
. Journal of Biomolecular Structure and Dynamics 39:12, pages 4225-4233.
Crossref
Crossref
Majid Hassanzadeganroudsari, Amir Ahmadi, Niloufar Rashidi, Md Hossain, Amanda Habib & Vasso Apostolopoulos. (2021) Computational Chemistry to Repurposing Drugs for the Control of COVID-19. Biologics 1:2, pages 111-128.
Crossref
Crossref
Nadezhda Palko, Maria Grishina & Vladimir Potemkin. (2021) Electron Density Analysis of SARS-CoV-2 RNA-Dependent RNA Polymerase Complexes. Molecules 26:13, pages 3960.
Crossref
Crossref
Shiwani Rana, Prateek Kumar, Anchal Sharma, Sanjay Sharma, Rajanish Giri & Kalyan S. Ghosh. (2021) Identification of Naturally Occurring Antiviral Molecules for SARS-CoV-2 Mitigation. The Open COVID Journal 1:1, pages 38-46.
Crossref
Crossref
Anurag Singh & Vandana Gupta. (2021) SARS-CoV-2 therapeutics: how far do we stand from a remedy?. Pharmacological Reports 73:3, pages 750-768.
Crossref
Crossref
Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne V. N.Uddhavesh Sonavane & Rajendra Joshi. (2021) Natural plant products as potential inhibitors of RNA dependent RNA polymerase of Severe Acute Respiratory Syndrome Coronavirus-2. PLOS ONE 16:5, pages e0251801.
Crossref
Crossref
Isabella Zanella, Daniela Zizioli, Francesco Castelli & Eugenia Quiros-Roldan. (2021) Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals 14:5, pages 454.
Crossref
Crossref
Yee Siew Choong, Theam Soon Lim, Hanyun Liu, Rubin Jiang, Zimu Cai & Yuan Ge. (2021) Potential Inhibition of COVID-19 RNA-dependent RNA Polymerase by Hepatitis C Virus Non-nucleoside Inhibitors: An In-silico Perspective. Letters in Drug Design & Discovery 18:5, pages 429-435.
Crossref
Crossref
G. Kanimozhi, B. Pradhapsingh, Charan Singh Pawar, Haseeb A. Khan, Salman H. Alrokayan & N. Rajendra Prasad. (2021) SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models. Frontiers in Pharmacology 12.
Crossref
Crossref
Vikas Kumar, Shraddha Parate, Sanghwa Yoon, Gihwan Lee & Keun Woo Lee. (2021) Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2. Frontiers in Microbiology 12.
Crossref
Crossref
Esraa M. O. A. Ismail, Shaza W. Shantier, Mona S. Mohammed, Hassan H. Musa, Wadah Osman & Ramzi A. Mothana. (2021) Quinoline and Quinazoline Alkaloids against COVID-19: An In Silico Multitarget Approach. Journal of Chemistry 2021, pages 1-11.
Crossref
Crossref
Mohd Saeed, Amir Saeed, Md Jahoor Alam & Mousa Alreshidi. (2021) Receptor-Based Pharmacophore Modeling in the Search for Natural Products for COVID-19 Mpro. Molecules 26:6, pages 1549.
Crossref
Crossref
Vladimir B. Sulimov, Danil C. Kutov, Anna S. Taschilova, Ivan S. Ilin, Eugene E. Tyrtyshnikov & Alexey V. Sulimov. (2021) Docking Paradigm in Drug Design. Current Topics in Medicinal Chemistry 21:6, pages 507-546.
Crossref
Crossref
Abdul Rouf Wani, Kanchan Yadav, Aadil Khursheed & Manzoor Ahmad Rather. (2021) An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses. Microbial Pathogenesis 152, pages 104620.
Crossref
Crossref
Hany M. Dabbous, Sherief Abd-Elsalam, Manal H. El-Sayed, Ahmed F. Sherief, Fatma F. S. Ebeid, Mohamed Samir Abd El Ghafar, Shaimaa Soliman, Mohamed Elbahnasawy, Rehab Badawi & Mohamed Awad Tageldin. (2021) RETRACTED ARTICLE: Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study. Archives of Virology 166:3, pages 949-954.
Crossref
Crossref
Nicola Borbone, Gennaro Piccialli, Giovanni Nicola Roviello & Giorgia Oliviero. (2021) Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses. Molecules 26:4, pages 986.
Crossref
Crossref
Zhihong Zuo, Ting Wu, Liangyu Pan, Chenzhe Zuo, Yingchuo Hu, Xuan Luo, Liping Jiang, Zanxian Xia, Xiaojuan Xiao, Jing Liu, Mao Ye & Meichun Deng. (2021) Modalities and Mechanisms of Treatment for Coronavirus Disease 2019. Frontiers in Pharmacology 11.
Crossref
Crossref
Mohadese Abidi, Reza Soheilifard & Reza Hasanzadeh Ghasemi. (2021) The effect of temperature on the binding affinity of Remdesivir and RdRp enzyme of SARS-COV-2 virus using steered molecular dynamics simulation. Journal of Control 14:5, pages 39-47.
Crossref
Crossref
Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M. H. Al-Hasani, Sajjad Ahmad & Guanglin Li. (2021) Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2. Molecules 26:3, pages 674.
Crossref
Crossref
Tofael Ahmed Sumon, Md. Ashraf Hussain, Md. Tawheed Hasan, Mahmudul Hasan, Won Je Jang, Eleus Hussain Bhuiya, Abdullah Al Mamun Chowdhury, S. M. Sharifuzzaman, Christopher Lyon Brown, Hyun-Ju Kwon & Eun-Woo Lee. (2021) A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic. Frontiers in Molecular Biosciences 7.
Crossref
Crossref
Yi Zhang & Liang V. Tang. (2020) Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication. Journal of Proteome Research 20:1, pages 49-59.
Crossref
Crossref
Manish Kumar Tripathi, Sujata Sharma, Tej P. Singh, A. S. Ethayathulla & Punit Kaur. 2021. Computational Intelligence Methods in COVID-19: Surveillance, Prevention, Prediction and Diagnosis. Computational Intelligence Methods in COVID-19: Surveillance, Prevention, Prediction and Diagnosis
273
294
.
Vinay Kumar & Kunal Roy. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses
541
578
.
Hoang Linh Nguyen, Nguyen Quoc Thai, Duc Toan Truong & Mai Suan Li. (2020) Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations. The Journal of Physical Chemistry B 124:50, pages 11337-11348.
Crossref
Crossref
Bruno Silva Andrade, Fernanda de Souza Rangel, Naiane Oliveira Santos, Andria dos Santos Freitas, Wagner Rodrigues de Assis Soares, Sérgio Siqueira, Debmalya Barh, Aristóteles Góes-Neto, Alexander Birbrair & Vasco Ariston de Carvalho Azevedo. (2020) Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review. Frontiers in Pharmacology 11.
Crossref
Crossref
Thakur Uttam Singh, Subhashree Parida, Madhu Cholenahalli Lingaraju, Manickam Kesavan, Dinesh Kumar & Raj Kumar Singh. (2020) Drug repurposing approach to fight COVID-19. Pharmacological Reports 72:6, pages 1479-1508.
Crossref
Crossref
Padmaja D. Wakchaure, Shibaji Ghosh & Bishwajit Ganguly. (2020) Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study. The Journal of Physical Chemistry B 124:47, pages 10641-10652.
Crossref
Crossref
Antonio Francés-Monerris, Cécilia Hognon, Tom Miclot, Cristina García-Iriepa, Isabel Iriepa, Alessio Terenzi, Stéphanie Grandemange, Giampaolo Barone, Marco Marazzi & Antonio Monari. (2020) Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches. Journal of Proteome Research 19:11, pages 4291-4315.
Crossref
Crossref
Sraa Abu-Melha, Mastoura M. Edrees, Sayed M. Riyadh, Mohamad R. Abdelaziz, Abdo A. Elfiky & Sobhi M. Gomha. (2020) Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (Mpro). Molecules 25:19, pages 4565.
Crossref
Crossref
Muhammad Asif, Mohammad Saleem, Malik Saadullah, Hafiza Sidra Yaseen & Raghdaa Al Zarzour. (2020) COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties. Inflammopharmacology 28:5, pages 1153-1161.
Crossref
Crossref
Rajneesh Srivastava, Swapna Vidhur Daulatabad, Mansi Srivastava & Sarath Chandra Janga. (2020) Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans. International Journal of Molecular Sciences 21:19, pages 7090.
Crossref
Crossref
Ognjen Perišić. (2020) Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein–Drug and Protein–Protein Structures: An Analysis of Kinetically Active Residues. Biomolecules 10:9, pages 1346.
Crossref
Crossref
Lenin González-Paz, José Luis Paz, Joan Vera-Villalobos & Ysaias J. Alvarado. (2020) Compuestos Fitoquímicos Dirigidos al Bloqueo de la Polimerasa Viral del SARS-CoV-2 Causante del COVID-19: un Análisis Comparativo de Funciones de Puntuación para Acoplamientos con Interés Biomédico. Revista Politécnica 46:1, pages 7-20.
Crossref
Crossref
Kate Stoeckle, Carrie D Johnston, Deanna P Jannat-Khah, Samuel C Williams, Tanya M Ellman, Mary A Vogler, Roy M Gulick, Marshall J Glesby & Justin J Choi. (2020) COVID-19 in Hospitalized Adults With HIV. Open Forum Infectious Diseases 7:8.
Crossref
Crossref
Shruti Koulgi, Vinod Jani, Mallikarjunachari V. N. Uppuladinne, Uddhavesh Sonavane & Rajendra Joshi. (2020) Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2. RSC Advances 10:45, pages 26792-26803.
Crossref
Crossref
Robert Bergquist & Anna-Sofie Stengaard. (2020) COVID-19: End of the beginning?. Geospatial Health 15:1.
Crossref
Crossref
Nilanjan Adhikari, Sk. Abdul Amin & Tarun Jha. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses
329
431
.
Vikas Pathak, Satyasai Jagannath Nanda, Amit Mahesh Joshi & Sitanshu Sekhar Sahu. (2021) Identification of Characteristics Frequency and Hot-Spots in Protein Sequence of COVID-19 Disease. SSRN Electronic Journal.
Crossref
Crossref